Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
146 Leser
Artikel bewerten:
(0)

Alliance for Pharmacy Compounding Joins Pharmacy Podcast Network with New "Essential" Podcast

With podcasting reaching over 210M people in the United States today, building reliable content for Providers and business professionals in healthcare is a crucial communication's tool.

BROWNSVILLE, PA / ACCESS Newswire / September 25, 2025 / The Alliance for Pharmacy Compounding has announced the launch of its official podcast, Essential: The Pharmacy Compounding Podcast. The podcast is a collaboration with the Pharmacy Podcast Network (PPN), the largest podcasting platform dedicated to the pharmacy profession.

"The name of the podcast - Essential - reflects the role pharmacy compounding plays in our healthcare system," said APC CEO Scott Brunner, CAE. "It's a compounding policy-focused podcast and is yet another way we're working to inform and educate about what law and regulation actually say about pharmacy compounding. Via Essential and our other communications, we're telling the truth about how compounded medications, prescribed based on the judgment of a licensed provider, benefit millions of Americans. We're excited to partner with PPN in this effort."

"It's critical to millions of people's health to have access to safely compounded medications which are tailored by pharmacists to meet a patient's specific needs when a standard, commercially available drug doesn't," said Todd Eury, founder and editor-in-chief of the Pharmacy Podcast Network. "We are thrilled to have APC as a member of the largest network of podcasts dedicated to our pharmacy profession."

About Essential: APC's New Podcast

The debut episode of Essential dives into some of the most pressing issues in compounding today, including:

  • FDA confusion and regulatory overreach impacting access to compounded medications.

  • California's latest compounding curveball for pharmacists

  • Pharma-driven myths surrounding GLP-1 medications.

  • Recent APC advocacy wins on Capitol Hill and how pharmacy tours can influence lawmakers.

  • The FDA's eyebrow-raising move to reclassify natural thyroid products -and what it means for patients nationwide.

By spotlighting both regulatory challenges and advocacy opportunities, Essential amplifies APC's mission to protect patient access to personalized medications while ensuring pharmacists' voices are heard in policy discussions.

Why Compounding Matters

Compounding allows pharmacists to create customized medication for an individual patient pursuant to a prescription. Pharmacists' ability to compound medications is authorized in federal law for good reason: Manufactured drugs don't come in dosages that are right for everyone, and prescribers must be able to prescribe customized medications when, in their judgment, a manufactured drug is not the best course of therapy for a patient or the appropriate FDA-approved drug is not available.

A Stronger Voice Through Podcasting

The Pharmacy Podcast Network, now celebrating more than 16 years of amplifying pharmacy voices, will help APC expand its reach and strengthen its advocacy strategy through podcasting. With more than 80,000 monthly listeners across 40+ shows, PPN provides APC with a powerful media platform to engage policymakers, healthcare leaders, and the public.

About the Alliance for Pharmacy Compounding (APC)

The Alliance for Pharmacy Compounding is the industry trade association and the voice for pharmacy compounding, representing more than 600 compounding small businesses - including 5,500+ compounding pharmacists and technicians in both 503A and 503B settings, as well as prescribers, educators, researchers, and suppliers. Learn more at compounding.com or a4pc.org.

About the Pharmacy Podcast Network (PPN)

Founded in 2009, the Pharmacy Podcast Network is the world's largest network of podcasts dedicated to the business and practice of pharmacy. PPN features more than 40 shows covering policy, innovation, education, and patient care. With over 5 million downloads and 80,000+ monthly listeners, PPN is the pharmacy profession's leading digital media voice. Learn more at www.pharmacypodcast.com.

Media Contact:
Todd Eury
RxPR, LLC
Email: eury@rxpr.com

SOURCE: Pharmacy Podcast Network



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/alliance-for-pharmacy-compounding-joins-pharmacy-podcast-network-with-1078011

© 2025 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.